AAAAAA

   
Results: 1-12 |
Results: 12
CONDITIONS FOR STAFF ACCEPTANCE OF ORGANIZATIONAL-CHANGE - BURNOUT ASA MEDIATING CONSTRUCT
Authors: LEITER MP HARVIE P
Citation: Mp. Leiter et P. Harvie, CONDITIONS FOR STAFF ACCEPTANCE OF ORGANIZATIONAL-CHANGE - BURNOUT ASA MEDIATING CONSTRUCT, Anxiety, stress, and coping, 11(1), 1998, pp. 1-25
THE CORRESPONDENCE OF PATIENT SATISFACTION AND NURSE BURNOUT
Authors: LEITER MP HARVIE P FRIZZELL C
Citation: Mp. Leiter et al., THE CORRESPONDENCE OF PATIENT SATISFACTION AND NURSE BURNOUT, Social science & medicine (1982), 47(10), 1998, pp. 1611-1617
PROTECTION AGAINST LEISHMANIA-MAJOR CHALLENGE INFECTION IN MICE VACCINATED WITH LIVE RECOMBINANT PARASITES EXPRESSING A CYTOTOXIC GENE
Authors: MUYOMBWE A OLIVIER M HARVIE P BERGERON MG OUELLETTE M PAPADOPOULOU B
Citation: A. Muyombwe et al., PROTECTION AGAINST LEISHMANIA-MAJOR CHALLENGE INFECTION IN MICE VACCINATED WITH LIVE RECOMBINANT PARASITES EXPRESSING A CYTOTOXIC GENE, The Journal of infectious diseases, 177(1), 1998, pp. 188-195
CHARACTERIZATION OF LIPID DNA INTERACTIONS - I - DESTABILIZATION OF BOUND LIPIDS AND DNA DISSOCIATION
Authors: HARVIE P WONG FMP BALLY MB
Citation: P. Harvie et al., CHARACTERIZATION OF LIPID DNA INTERACTIONS - I - DESTABILIZATION OF BOUND LIPIDS AND DNA DISSOCIATION, Biophysical journal, 75(2), 1998, pp. 1040-1051
ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN AND FOSCARNET EACH GIVENALONE OR IN COMBINATION IN THE MURINE AIDS MODEL
Authors: OMAR RF HARVIE P GOURDE P DESORMEAUX A TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: Rf. Omar et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN AND FOSCARNET EACH GIVENALONE OR IN COMBINATION IN THE MURINE AIDS MODEL, Toxicology and applied pharmacology, 143(1), 1997, pp. 140-151
ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL
Authors: HARVIE P OMAR RF DUSSERRE N DESORMEAUX A GOURDE P TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 451-461
COMPARATIVE PHARMACOKINETICS, DISTRIBUTIONS IN TISSUE, AND INTERACTIONS WITH BLOOD PROTEINS OF CONVENTIONAL AND STERICALLY STABILIZED LIPOSOMES CONTAINING 2',3'-DIDEOXYINOSINE
Authors: HARVIE P DESORMEAUX A BERGERON MC TREMBLAY M BEAUCHAMP D POULIN L BERGERON MG
Citation: P. Harvie et al., COMPARATIVE PHARMACOKINETICS, DISTRIBUTIONS IN TISSUE, AND INTERACTIONS WITH BLOOD PROTEINS OF CONVENTIONAL AND STERICALLY STABILIZED LIPOSOMES CONTAINING 2',3'-DIDEOXYINOSINE, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 225-229
RIBAVIRIN POTENTIATES THE EFFICACY AND TOXICITY OF 2',3'-DIDEOXYINOSINE IN THE MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL
Authors: HARVIE P OMAR RF DUSSERRE N LANSAC N DESORMEAUX A GOURDE P SIMARD M TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., RIBAVIRIN POTENTIATES THE EFFICACY AND TOXICITY OF 2',3'-DIDEOXYINOSINE IN THE MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 1009-1017
LYMPHOID-TISSUES TARGETING OF LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE
Authors: HARVIE P DESORMEAUX A GAGNE N TREMBLAY M POULIN L BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., LYMPHOID-TISSUES TARGETING OF LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE, AIDS, 9(7), 1995, pp. 701-707
ANTIVIRAL EFFICACY, INTRACELLULAR UPTAKE AND PHARMACOKINETICS OF FREEAND LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE
Authors: DESORMEAUX A HARVIE P PERRON S MAKABIPANZU B BEAUCHAMP D TREMBLAY M POULIN L BERGERON MG
Citation: A. Desormeaux et al., ANTIVIRAL EFFICACY, INTRACELLULAR UPTAKE AND PHARMACOKINETICS OF FREEAND LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE, AIDS, 8(11), 1994, pp. 1545-1553
ANTIVIRAL EFFICACY, INTRACELLULAR UPTAKE AND PHARMACOKINETICS OF FREEAND LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE
Authors: DESORMEAUX A HARVIE P PERRON S MAKABIPANZU B BEAUCHAMP D TREMBLAY M POULIN L BERGERON MG
Citation: A. Desormeaux et al., ANTIVIRAL EFFICACY, INTRACELLULAR UPTAKE AND PHARMACOKINETICS OF FREEAND LIPOSOME-ENCAPSULATED 2',3'-DIDEOXYINOSINE, AIDS, 8(11), 1994, pp. 1545-1553
TISSUE-SPECIFIC AND LIGHT REGULATION OF A LARCH RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE PROMOTER IN TRANSGENIC TOBACCO
Authors: CAMPBELL MA NEALE DB HARVIE P HUTCHISON KW
Citation: Ma. Campbell et al., TISSUE-SPECIFIC AND LIGHT REGULATION OF A LARCH RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE PROMOTER IN TRANSGENIC TOBACCO, Canadian journal of forest research, 24(8), 1994, pp. 1689-1693
Risultati: 1-12 |